Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
1,64 USD | 0,00 % | +0,61 % | -44,03 % |
11/04 | CARISMA THERAPEUTICS, INC. : Recibe una recomendación de compra del BTIG | ZM |
02/04 | CARISMA THERAPEUTICS, INC. : HC Wainwright mantiene su recomendación de compra | ZM |
Resumen de negocios
Número de empleados: 107
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Founder | 34 | 01/01/16 | |
Steven Kelly
CEO | Chief Executive Officer | 59 | 01/02/18 |
Richard Morris
DFI | Director of Finance/CFO | 51 | 01/06/21 |
Daniel Cushing
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/17 |
Tom Wilton
PRN | Corporate Officer/Principal | - | 01/09/19 |
Terry Shields
HRO | Human Resources Officer | - | 14/06/23 |
Eric Siegel
LAW | General Counsel | 60 | 14/06/23 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Steven Kelly
CEO | Chief Executive Officer | 59 | 01/02/18 |
Sanford Zweifach
CHM | Chairman | 68 | 01/11/21 |
Director/Board Member | 66 | 01/02/22 | |
Regina Hodits
BRD | Director/Board Member | 54 | 01/06/18 |
Briggs Morrison
BRD | Director/Board Member | 65 | 01/07/20 |
Michael Torok
BRD | Director/Board Member | 45 | 07/03/23 |
John Hohneker
BRD | Director/Board Member | 64 | 01/04 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 41 542 534 | 27 945 479 ( 67,27 %) | 0 | 67,27 % |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-44,03 % | 68,13 M | |
-2,31 % | 103 mil M | |
+0,56 % | 95,71 mil M | |
+1,69 % | 22,02 mil M | |
-17,37 % | 20,9 mil M | |
-9,30 % | 17,85 mil M | |
-41,01 % | 16,21 mil M | |
-14,85 % | 15,52 mil M | |
+3,21 % | 13,86 mil M | |
+33,54 % | 12,04 mil M |
- Bolsa de valores
- Acciones
- Acción CARM
- Empresa Carisma Therapeutics, Inc.